Aerovance's Series C - II Round

Aerovance raised a round of funding on April 22, 2009.

Aerovance is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for respiratory and allergic diseases. Aerovance's lead programs are in developmen…

Articles about Aerovance's Series C - II Round: